Head injury outcome prediction: A role for protein S-100B?

被引:54
作者
Townend, Will
Ingebrigtsen, Tor
机构
[1] Hull Royal Infirm, Emergency Dept, Kingston Upon Hull HU3 2JZ, N Humberside, England
[2] Univ No Norway, Dept Neurosurg, Tromso, Norway
来源
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED | 2006年 / 37卷 / 12期
关键词
review; biomarker; craniocerebral trauma; serum; S-100B; diagnostic studies; sensitivity; outcome; disability; neuropsychological;
D O I
10.1016/j.injury.2006.07.014
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Prediction of the likely outcome of head injury from the outset would allow early rehabilitation to be targeted at those with most to gain. Clinical evaluation of a head injured patient may be confounded by intoxicants such as alcohol. Imaging modalities are insensitive (CT) or impractical (MR) for screening populations of such patients. A peripheral marker that reflected the extent of brain injury might offer an objective indication of likely adverse sequelae. This review evaluates the evidence for Protein S-100B as such a marker. Methods: A search of published literature revealed 18 studies designed to evaluate the relation between serum S-100B and measures of outcome after head injury. Results: A cut-off point of 2.5 mu g/L is related to dependent disability in those presenting with low conscious level, and may be a specific test for this. There appears to be a relation between initial serum S-100B concentration and measures of disability as well as post-concussion symptoms for those with seemingly mild injuries. There does not appear to be a relation between S-100B and measures of neuropsychological performance. Conclusion: Patients with high levels of S-100B at initial assessment (>2.5 mu g/L) may represent a high risk group for disability after head trauma. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1098 / 1108
页数:11
相关论文
共 43 条
[1]  
ALTMAN D, STAT CONFIDENCE, P110
[2]   High serum S100B levels for trauma patients without head injuries [J].
Anderson, RE ;
Hansson, LO ;
Nilsson, O ;
Dijlai-Merzoug, R ;
Settergren, G .
NEUROSURGERY, 2001, 48 (06) :1255-1258
[3]   ENZYMATIC CHANGES IN SERUM AND CEREBROSPINAL-FLUID IN NEUROLOGICAL INJURY [J].
BAKAY, RAE ;
WARD, AA .
JOURNAL OF NEUROSURGERY, 1983, 58 (01) :27-37
[4]   Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCE .
BRITISH MEDICAL JOURNAL, 2003, 326 (7379) :41-44
[5]  
Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1
[6]   Discordant temporal patterns of S100β and cleaved tau protein elevation after head injury:: a pilot study [J].
Chatfield, DA ;
Zemlan, FP ;
Day, DJ ;
Menon, DK .
BRITISH JOURNAL OF NEUROSURGERY, 2002, 16 (05) :471-476
[7]   The Rivermead head injury follow up questionnaire: A study of a new rating scale and other measures to evaluate outcome after head injury [J].
Crawford, S ;
Wenden, FJ ;
Wade, DT .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (05) :510-514
[8]   S100 and cognitive impairment after mild traumatic brain injury [J].
de Boussard, CN ;
Lundin, A ;
Karlstedt, D ;
Edman, G ;
Bartfai, A ;
Borg, J .
JOURNAL OF REHABILITATION MEDICINE, 2005, 37 (01) :53-57
[9]   S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients - A comparison with healthy controls [J].
de Kruijk, JR ;
Leffers, P ;
Menheere, PPCA ;
Meerhoff, S ;
Twijnstra, A .
ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (03) :175-179
[10]   Prospective validation of a proposal for diagnosis and management of patients attending the emergency department for mild head injury [J].
Fabbri, A ;
Servadei, F ;
Marchesini, G ;
Morselli-Labate, AM ;
Dente, M ;
Iervese, T ;
Spada, M ;
Vandelli, A .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (03) :410-416